Takeda Pharmaceutical Company Limited Noncurrent Recognised Liabilities Defined Benefit Plan
Takeda Pharmaceutical Company Limited (TAK) had Noncurrent Recognised Liabilities Defined Benefit Plan of JPY 135.43 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan · last filed 2025-06-25
- 2025-03-31: Noncurrent Recognised Liabilities Defined Benefit Plan 135.43B JPY.
- 2024-03-31: Noncurrent Recognised Liabilities Defined Benefit Plan 143.88B JPY.
- 2023-03-31: Noncurrent Recognised Liabilities Defined Benefit Plan 127.59B JPY.
- 2022-03-31: Noncurrent Recognised Liabilities Defined Benefit Plan 145.85B JPY.
| Period end | Noncurrent Recognised Liabilities Defined Benefit Plan |
|---|---|
| 2025-03-31 | 135.43B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 143.88B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 127.59B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 145.85B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 158.86B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 156.62B JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 156.51B JPY 20-F · filed 2020-06-24 |
| 2018-03-31 | 87.61B JPY 20-F · filed 2019-06-27 |